About | Support Us | Contact
Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.
Home Page > Grant Page

Preclinical Studies of Novel Agents for Lung Cancer

Institution: University of California, San Diego
Investigator(s): Michael Kelner, M.D., M.S.
Award Cycle: 1992 (Cycle 1) Grant #: 1KT-0001 Award: $225,000
Subject Area: Cancer
Award Type: New Investigator Awards
Abstracts
Publications
Preclinical evaluation of illudins as anti-cancer agents: Basis for selective cytotoxicity
Periodical: Journal of the National Cancer Institute Index Medicus:
Authors: Kelner MJ, McMorris TC, Taetle R ART
Yr: 1990 Vol: 82 Nbr: Abs: Pg: 1562-1565
Repair of illudin induced DNA damage requires involvement of ERCC-2 and ERCC-3 DNA repair proteins prior to ERCC-1 action
Periodical: Toxicologist Index Medicus:
Authors: McMorris TC, Kelner MJ ABS
Yr: 1992 Vol: 12 Nbr: Abs: Pg: 155
HPLC determination of a new anticancer agent (acylfulvene) in serum
Periodical: Neoplasma Index Medicus:
Authors: Brandsteterova E, Kelner MJ, McMorris TC, Estes L, Bagnell R, Montoya M ART
Yr: 1992 Vol: 39 Nbr: 6 Abs: Pg: 369-373
Structure activity-relationships of illudins: analogs with improved therapeutic index
Periodical: Index Medicus:
Authors: McMorris TC, Kelner MJ, Wang W, Estes LA, Montoya MM, Taetle R ART
Yr: 1992 Vol: 57 Nbr: 25 Abs: Pg: 6876-6883
HPLC analysis of novel anticancer agents - illudins and their analogs
Periodical: Journal of Liquid Chromatography Index Medicus:
Authors: Brandsteterova E, Kelner MJ, McMorris TC, Wang W, Bagnell R ART
Yr: 1993 Vol: 16 Nbr: 1 Abs: Pg: 115-125
Characterization of the energy-dependent illudin transport system in immortal and tumor cells
Periodical: Toxicologist Index Medicus:
Authors: Kelner MJ, McMorris TC ABS
Yr: 1993 Vol: 13 Nbr: Abs: 1214 Pg: 315
On the mechanism of toxicity of illudins
Periodical: Index Medicus:
Authors: McMorris TC, Kelner MJ, Wang W, Moon S, Taetle R ART
Yr: 1990 Vol: 3 Nbr: Abs: Pg: 574-579
Preclinical evaluation of illudins as anti-cancer agents: Basis for selective cytotoxicity
Periodical: Journal of the National Cancer Institute Index Medicus:
Authors: Kelner MJ, McMorris TC, Taetle R ART
Yr: 1990 Vol: 82 Nbr: Abs: Pg: 1562-1565
Repair of illudin induced DNA damage requires involvement of ERCC-2 and ERCC-3 DNA repair proteins prior to ERCC-1 action
Periodical: Toxicologist Index Medicus:
Authors: McMorris TC, Kelner MJ ABS
Yr: 1992 Vol: 12 Nbr: Abs: Pg: 155
HPLC determination of a new anticancer agent (acylfulvene) in serum
Periodical: Neoplasma Index Medicus:
Authors: Brandsteterova E, Kelner MJ, McMorris TC, Estes L, Bagnell R, Montoya M ART
Yr: 1992 Vol: 39 Nbr: 6 Abs: Pg: 369-373
Structure activity-relationships of illudins: analogs with improved therapeutic index
Periodical: Index Medicus:
Authors: McMorris TC, Kelner MJ, Wang W, Estes LA, Montoya MM, Taetle R ART
Yr: 1992 Vol: 57 Nbr: 25 Abs: Pg: 6876-6883
HPLC analysis of novel anticancer agents - illudins and their analogs
Periodical: Journal of Liquid Chromatography Index Medicus:
Authors: Brandsteterova E, Kelner MJ, McMorris TC, Wang W, Bagnell R ART
Yr: 1993 Vol: 16 Nbr: 1 Abs: Pg: 115-125
Characterization of the energy-dependent illudin transport system in immortal and tumor cells
Periodical: Toxicologist Index Medicus:
Authors: Kelner MJ, McMorris TC ABS
Yr: 1993 Vol: 13 Nbr: Abs: 1214 Pg: 315
On the mechanism of toxicity of illudins
Periodical: Index Medicus:
Authors: McMorris TC, Kelner MJ, Wang W, Moon S, Taetle R ART
Yr: 1990 Vol: 3 Nbr: Abs: Pg: 574-579